Table 2: Carotid paragangliomas (CPG) related tosyndromes and diseases. Literature review.
|
CPG & Syndromes |
CPG & Diseases |
Total |
Cases, n Gender, male/female Age, mean* Age, mean (male/female) CPG bilateral, n (%) CPG malignant, n (%) CPG functional, n (%) Other PGs/PHEO, n (%) Other tumours, n (%)** Genetic studies (positive) CPG surgery, n/total Mortality reported |
17 3/3 (11 NR) 29.5 + 5.0 (11 NR) 28.3/30.7 2 (11.8%) 1 (5.9%) 1 (5.9%) 6 (35.3%) 0 3/3 (14 NR) 6/7 (10 NR) NR |
20 6/12 (2 NR) 46.1 + 3.6 (2 NR) 45.8/46.1 8 (40.0%) 0 0 5 (25.0%) 8 (40.0%) 7/9 (11 NR) 13/15 (5 NR) 2 cases |
37 9/15 (13 NR) 41.9 + 3.9 (13 NR) 40.0/43.1 10 (27.0%) 1 (2.7%) 1 (2.7%) 11 (29.7%) 8 (21.6%) 10/12 (25 NR) 19/22 (15 NR) 2 cases |
CPG: Carotid Paraganglioma; PHEO: Pheochromocytoma; NR: Not reported.
*Age in CPG & Syndromes vs. CPG & Diseases: p = 0.012 (Student's t-test).
**Unrelated to these syndromes or diseases.